Latest filing published 21 Aug 2025 for Option Care Health, Inc., €24k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David W. Golding, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Option Care Health, Inc. and Caremark RX Inc. Over a trading history stretching from 22 March 2007 to 21 August 2025, the count stands at 19 filings.
Purchases make up the whole of the open-market record (4 purchases, €115k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 share grants and 1 option exercise. In 2025 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €28k.
The newest entry dates from 21 August 2025: an open-market purchase of €24k, in Option Care Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations